KPIs & Operating Metrics(New)
Breakdown Of AssetsContractual ObligationCost Of RevenueCustomer Additions AnnualCustomers Count AnnualDeferred RevenueEmployee StatisticsGross Margin %Gross ProfitIncome (Loss) Before Income Taxes By RegionLong Lived AssetsNon Gaap ProfitabilityNon Gaap Profitability %Non Gaap Profitability AnnualNo. Of Genes ShippedNo. Of Genes Shipped AnnualNo. Of Orders TotalNo. Of Orders Total AnnualNo. Of ShipmentsOpex As A % Of Total Revenue %OPEX SegregationOrder BreakdownProperty And Equipment, Net BreakdownRevenue By GeographyRevenue By Geography %Revenue By Geography AnnualRevenue By Geography Annual %Revenue By IndustryRevenue By Industry %Revenue By Industry AnnualRevenue By Industry Annual %Revenue By ProductRevenue By Product %Revenue By Product AnnualRevenue By Product Annual %Revenue Mix From Repeat Customers %Shipped ProductsValue Of Orders
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Twist Bioscience (TWST) Cost Of Revenue (2018 - 2025)

Historic Cost of Revenue for Twist Bioscience (TWST) over the last 8 years, with Q4 2025 value amounting to $49.7 million.

  • Twist Bioscience's Cost of Revenue rose 839.93% to $49.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $189.4 million, marking a year-over-year increase of 353.08%. This contributed to the annual value of $185.6 million for FY2025, which is 330.97% up from last year.
  • As of Q4 2025, Twist Bioscience's Cost of Revenue stood at $49.7 million, which was up 839.93% from $48.2 million recorded in Q3 2025.
  • Twist Bioscience's Cost of Revenue's 5-year high stood at $49.7 million during Q4 2025, with a 5-year trough of $19.0 million in Q1 2021.
  • For the 5-year period, Twist Bioscience's Cost of Revenue averaged around $37.6 million, with its median value being $42.1 million (2023).
  • As far as peak fluctuations go, Twist Bioscience's Cost of Revenue skyrocketed by 5615.93% in 2022, and later tumbled by 310.22% in 2025.
  • Over the past 5 years, Twist Bioscience's Cost of Revenue (Quarter) stood at $27.1 million in 2021, then rose by 8.82% to $29.4 million in 2022, then surged by 44.47% to $42.5 million in 2023, then increased by 7.85% to $45.9 million in 2024, then grew by 8.4% to $49.7 million in 2025.
  • Its last three reported values are $49.7 million in Q4 2025, $48.2 million for Q3 2025, and $44.8 million during Q2 2025.